Search Results
bb2121: a promising outlook for the future of multiple myeloma
Dr. Berdeja Discusses Next Steps With bb2121 in Multiple Myeloma
Dr. Raje Discusses the Tolerability of bb2121 in Myeloma
From bb2121 to bb21217: does bb007 improve efficacy in MM?
ide-cel; bb2121, a BCMA-targeted CAR T-cell therapy, in patients with RRMM: Initial KarMMa results
Future myeloma treatment strategies
Dr. Anderson on Future Treatment Landscape of Multiple Myeloma
Anti-BCMA CAR T-cells for MM: durable clinical responses with ide-cel (formerly bb2121)
Phase I CRB-402 Study of the BCMA-Targeted CAR T Cell Therapy bb21217 in Pts w/RR Multiple Myeloma
Increasingly Improved Outcomes for Multiple Myeloma
The Future of Multiple Myeloma Management
BCMA-Directed CAR T-Cell Therapy: Outlook
